Robot-Assisted Stereotactic Biopsies in 377 Consecutive Adult Patients with Supratentorial Diffuse Gliomas: Diagnostic Yield, Safety, and Postoperative Outcomes
- PMID: 33412330
- DOI: 10.1016/j.wneu.2020.12.127
Robot-Assisted Stereotactic Biopsies in 377 Consecutive Adult Patients with Supratentorial Diffuse Gliomas: Diagnostic Yield, Safety, and Postoperative Outcomes
Abstract
Background: Multiple biopsy samples are warranted for the histomolecular diagnosis of diffuse gliomas in the current molecular era, which possibly increases morbidity.
Objective: We assessed diagnostic yield, safety, and risk factors of postoperative morbidity after robot-assisted serial stereotactic biopsy sampling along 1 biopsy trajectory for diffuse gliomas.
Methods: Observational retrospective analysis of consecutive magnetic resonance imaging-based robot-assisted stereotactic biopsies performed at a single institution to assess the diagnosis of nonresectable newly diagnosed supratentorial diffuse gliomas in adults (2006-2016).
Results: In 377 patients, 4.2 ± 1.9 biopsy samples were obtained at 2.6 ± 1.2 biopsy sites. The histopathologic diagnosis was obtained in 98.7% of cases. Preoperative neurologic deficit (P = 0.030), biopsy site hemorrhage ≥20 mm (P = 0.004), and increased mass effect on postoperative imaging (P = 0.014) were predictors of a new postoperative neurologic deficit (7.7%). Postoperative neurologic deficit (P < 0.001) and increased mass effect on postoperative imaging (P = 0.014) were predictors of a Karnofsky Performance Status decrease ≥20 points postoperatively (4.0%). Increased intracranial pressure preoperatively (P = 0.048) and volume of the contrast-enhanced area ≥13 cm3 (P = 0.048) were predictors of an increased mass effect on postoperative imaging (4.4%). Preoperative Karnofsky Performance Status <70 (P = 0.045) and increased mass effect on postoperative imaging (P < 0.001) were predictors of mortality 1 month postoperatively (2.9%). Preoperative neurologic deficit (P = 0.005), preoperative Karnofsky Performance Status <70 (P < 0.001), subventricular zone contact (P = 0.004), contrast enhancement (P = 0.018), and steroid use (P = 0.003), were predictors of the inability to discharge to home postoperatively (37.0%).
Conclusions: Robot-assisted stereotactic biopsy sampling results in high diagnostic accuracy with low complication rates. Multiple biopsy sites and samples do not increase postoperative complications.
Keywords: Glioma; Neuropathology; Patient discharge; Robotic surgical procedures; Stereotaxic techniques.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Robot-assisted stereotactic brain biopsy: A systematic review and meta-analysis.Neurosurg Rev. 2024 Dec 4;47(1):886. doi: 10.1007/s10143-024-03122-4. Neurosurg Rev. 2024. PMID: 39627622
-
[Significance of stereotactic biopsy for the management of WHO grade II supratentorial glioma].Nervenarzt. 2003 Apr;74(4):350-4. doi: 10.1007/s00115-003-1487-4. Nervenarzt. 2003. PMID: 12707704 German.
-
Resection of gliomas deemed inoperable by neurosurgeons based on preoperative imaging studies.J Neurosurg. 2018 Sep;129(3):567-575. doi: 10.3171/2017.5.JNS17166. Epub 2017 Nov 10. J Neurosurg. 2018. PMID: 29125414
-
Robot-Assisted Stereotactic Biopsy of Diffuse Intrinsic Pontine Glioma: A Single-Center Experience.World Neurosurg. 2017 May;101:584-588. doi: 10.1016/j.wneu.2017.02.088. Epub 2017 Feb 27. World Neurosurg. 2017. PMID: 28254596
-
Comparative Analysis of Efficacy and Safety of Frame-Based, Frameless, and Robot-Assisted Stereotactic Brain Biopsies: A Systematic Review and Meta-Analysis.Oper Neurosurg. 2025 Jun 1;28(6):749-761. doi: 10.1227/ons.0000000000001408. Epub 2024 Nov 7. Oper Neurosurg. 2025. PMID: 40062857
Cited by
-
Accuracy and safety of 101 consecutives neurosurgical procedures for newly diagnosed central nervous system lymphomas: a single-institution experience.J Neurooncol. 2022 Sep;159(2):347-358. doi: 10.1007/s11060-022-04069-6. Epub 2022 Jun 27. J Neurooncol. 2022. PMID: 35759152
-
Diagnostic yield of intraoperative frozen sections obtained through robot-assisted stereotactic biopsy of brain lesions.Front Neurol. 2025 Jun 10;16:1544613. doi: 10.3389/fneur.2025.1544613. eCollection 2025. Front Neurol. 2025. PMID: 40556650 Free PMC article.
-
Safety and efficacy of frameless stereotactic robot-assisted intraparenchymal brain lesion biopsies versus image-guided biopsies: a bicentric comparative study.Acta Neurochir (Wien). 2024 Feb 6;166(1):67. doi: 10.1007/s00701-024-05912-7. Acta Neurochir (Wien). 2024. PMID: 38319393
-
Robot-assisted stereotactic brain biopsy: A systematic review and meta-analysis.Neurosurg Rev. 2024 Dec 4;47(1):886. doi: 10.1007/s10143-024-03122-4. Neurosurg Rev. 2024. PMID: 39627622
-
LITTing up Gliomas-Is the Future Bright?World Neurosurg X. 2022 Sep 9;17:100136. doi: 10.1016/j.wnsx.2022.100136. eCollection 2023 Jan. World Neurosurg X. 2022. PMID: 36267388 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical